Michael Paulzen, Gerhard Gründer. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AmisulprideAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useAripiprazoleDopamine Agonists/therapeutic useDopamine Antagonists/adverse effectsDrug Therapy, CombinationFemaleHumansHyperprolactinemia/chemically inducedHyperprolactinemia/drug therapyMiddle AgedPiperazines/therapeutic useQuinolones/therapeutic useSchizophrenia/drug therapySulpiride/adverse effectsSulpiride/analogs & derivativesTreatment Failure
Substances: See more » Antipsychotic AgentsDopamine AgonistsDopamine AntagonistsPiperazinesQuinolonesSulpirideAmisulprideAripiprazole
Year: 2006 PMID: 16942633 DOI: 10.1017/S1461145706007115
Source DB: PubMed Journal: Int J Neuropsychopharmacol ISSN: 1461-1457 Impact factor: 5.176